- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Cathepsin D (CTSD) is a lysosomal aspartyl protease that functions as a key mediator of intracellular protein processing and degradation, playing central roles in lysosomal function, apoptosis, and tissue remodeling. The Cathepsin D Antibody / CTSD Lysosomal Protease Antibody is widely used to detect this enzyme across diverse biological systems, where it is primarily localized to lysosomes but may also be secreted or redistributed under specific physiological and pathological conditions. CTSD is encoded on chromosome 11p15.5 and belongs to the pepsin-like aspartic protease family, characterized by proteolytic activity under acidic conditions and involvement in the breakdown of intracellular substrates.
The Cathepsin D antibody, also referred to as CTSD antibody and Aspartyl protease cathepsin D antibody in the literature, recognizes a protein that is synthesized as a preproenzyme and undergoes sequential proteolytic processing to generate intermediate and mature active forms. The precursor form is approximately 52 kDa and is cleaved into a mature enzyme consisting of heavy and light chains, typically observed as bands in the 30-35 kDa range in western blot analysis. This maturation process is a defining feature of CTSD biology and reflects its activation within lysosomal compartments, making it a valuable marker for studying proteolytic processing pathways.
This Cathepsin D Antibody / CTSD Lysosomal Protease Antibody is uniquely positioned for studies focused on lysosomal activity and protein turnover. Detection of both precursor and processed forms provides insight into enzyme maturation, intracellular trafficking, and functional state. In immunohistochemistry and immunofluorescence applications, CTSD typically exhibits punctate cytoplasmic staining consistent with lysosomal localization, while in western blot analysis, distinct banding patterns reflect its proteolytic processing. These features make CTSD an informative marker for evaluating lysosomal integrity and protease activity.
Cathepsin D is broadly expressed across tissues, including brain, liver, pancreas, and epithelial compartments, where it contributes to normal cellular homeostasis through regulated protein degradation. In addition to its physiological roles, CTSD is implicated in multiple pathological conditions, including cancer, neurodegenerative disorders, and inflammatory diseases. Elevated expression and secretion of Cathepsin D have been associated with tumor progression, invasion, and metastasis, particularly in breast cancer and other epithelial malignancies, highlighting its relevance as both a functional enzyme and disease-associated biomarker.
The mouse monoclonal clone CTSD/3276 provides consistent and specific detection of CTSD, supported by protein microarray specificity validation data demonstrating selective binding to the intended target. This Cathepsin D Antibody / CTSD Lysosomal Protease Antibody is suitable for detecting CTSD expression in research applications where lysosomal function, proteolytic maturation, and intracellular protein processing are of primary interest. It supports detailed investigation of lysosomal protease activity, protein maturation, and disease-associated changes in CTSD expression.
This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Optimal dilution of the Cathepsin D Antibody / CTSD Lysosomal Protease Antibody should be determined by the researcher.
A recombinant human partial protein (amino acids 104-250) was used as the immunogen of the Cathepsin D antibody.
Store the Cathepsin D antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Cathepsin D antibody, CTSD antibody, Cathepsin D lysosomal enzyme antibody, CTSD protease antibody, Aspartyl protease cathepsin D antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.